CAC Software vs Imbio PHA (4.0.0)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
AI Verdict
These two tools, both from Imbio, operate within the Cardiology AI domain but address distinct clinical needs. Tool A focuses on quantifying coronary artery calcification from non-contrast chest CTs for cardiovascular risk assessment. In contrast, Tool B analyzes CT pulmonary angiograms (CTPAs) to measure cardiac structures for the diagnosis and risk stratification of pulmonary embolism and hypertension.
Choose CAC Software if…
Choose Imbio's CAC Software if your primary objective is to accurately quantify coronary artery calcification from non-contrast chest CT scans to assess a patient's risk for coronary artery disease. This tool is ideal for radiologists and cardiologists seeking automated Agatston scores, arterial age, and 3D visualizations to inform preventative care and treatment strategies.
View CAC Software →Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if you require automated analysis of CT pulmonary angiogram (CTPA) scans to precisely measure cardiac structures, especially for assessing right ventricular dilation. This software is best suited for aiding in the diagnosis and risk stratification of conditions such as pulmonary embolism and pulmonary hypertension by providing critical RV/LV and PA/Ao ratios.
View Imbio PHA (4.0.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | Imbio PHA (4.0.0) |
|---|---|---|
| Deployment | Cloud-based (SaaS), integrates with PACS | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | Imbio PHA (4.0.0) |
|---|---|---|
| Name | CAC Software | Imbio PHA (4.0.0) |
| Description | Automated image post-processing algorithms to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. |
| Company | Imbio | Imbio |
| Key Features | Automated image post-processing for coronary artery calcification; Quantification of calcification within coronary arteries; Outputs Agatston score, arterial age, calcified lesion mass and volume; Provides 3D visualizations and annotated images; Non-invasive analysis from non-contrast chest CT scans; Integrates into existing DICOM viewing workflow; Supports risk assessment for coronary artery disease; Deep-learning based analysis | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement; Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows; Rapid, fully-automated assessment (typically in minutes) |
| Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and Imbio PHA (4.0.0).
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Imbio's CAC Software is designed to analyze non-contrast chest CT scans, including both gated and non-gated acquisitions, to evaluate coronary artery calcification. Imbio PHA (4.0.0) processes contrast-enhanced CT pulmonary angiogram (CTPA) scans for automated cardiac structure measurements.
The CAC Software is intended to aid in risk assessment for coronary artery disease by quantifying calcification within the coronary arteries. Imbio PHA (4.0.0) assists in the diagnosis and risk stratification of pulmonary embolism and hypertension by automatically measuring cardiac structures to assess potential right ventricular dilation.
The CAC Software provides quantitative outputs including the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images. Imbio PHA (4.0.0) delivers automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios, generating annotated DICOM images and PDF summary reports.
Both Imbio CAC Software and Imbio PHA (4.0.0) are designed for fully automated integration into existing DICOM viewing workflows and native DICOM tools. They automatically receive image series, process them, and return results, including annotated DICOM images and summary reports, directly to PACS.
Both Imbio CAC Software and Imbio PHA (4.0.0) are FDA-cleared and HIPAA compliant. Imbio PHA (4.0.0) is specifically third-party certified by Compliancy Group for HIPAA compliance, and both offer a Business Associate Agreement (BAA).
The CAC Software is primarily intended for use by radiologists and cardiologists. Imbio PHA (4.0.0) is designed for use by cardiologists, pulmonologists, and radiologists.